NCYTNovacyt S.A.
40.70GBP-5.35%Mkt Cap: 37.85M $P/E:

Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmenta…

Key Statistics

Company
Market Cap37.85M $
Enterprise Value25.56M $
Revenue (TTM)25.69M $
Gross Profit16.18M $
Net Income (TTM)-29.35M $
Revenue/Share0.3643 USD
Last Price40.70 GBP
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees216
CountryGB
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-5.84
PEG
EV/EBITDA7.69
EV/Revenue1.00
P/S1.47
P/B1.23
EPS (TTM)-0.33
EPS (Forward)-0.07
52W Range
26.6024% of range86.00
52W High86.00 GBP
52W Low26.60 GBP
Profitability
Gross Margin62.98%
Oper. Margin-59.36%
EBITDA Margin12.95%
Profit Margin-114.25%
ROE-97.91%
ROA-56.74%
Growth
Revenue Growth6.00%
Earnings Growth
Cash Flow & Leverage
Operating CF-11.55M $
CapEx (TTM)1.13M $
FCF Margin36.82%
FCF Yield24.99%
Net Debt-11.31M $
Net Debt/EBITDA-3.40
Balance Sheet
Debt/Equity0.45
Current Ratio4.75
Quick Ratio4.16
Book Value/Sh0.3310 GBP
Cash/Share0.2730 GBP
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 GBP
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)66.00 GBP
Upside (mean)+62.2%
Target Range66.00 GBP66.00 GBP
# Analysts1
Ownership
Shares Out.72.50M
Float70.41M
Insiders0.06%
Institutions0.00%
Technical
SMA 5037.36 (+8.9%)
SMA 20037.09 (+9.7%)
Beta1.11
S&P 52W Chg18.16%
Avg Vol (30d)69.78K
Avg Vol (10d)134.34K
Technical Indicators
RSI (14)52.3
MACD1.7275
MACD Signal1.2112
MACD Hist.+0.5164
BB Upper46.47 GBP
BB Middle39.49 GBP
BB Lower32.50 GBP
BB Width35.40%
ATR (14)2.748 GBP
Vol Ratio (20d)0.90x